The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Safronenko A.V.

GBOU VPO "Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdravsotsrazvitiia RF"

Makliakov Iu.S.

GBOU VPO "Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdravsotsrazvitiia RF"

Demidov I.A.

GBOU VPO "Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdravsotsrazvitiia RF"

Lavnik D.V.

GBOU VPO "Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdravsotsrazvitiia RF"

Luk'ianchikov M.K.

GBOU VPO "Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdravsotsrazvitiia RF"

Condition and functional reserves of endothelium in patients with refractory arterial hypertension

Authors:

Safronenko A.V., Makliakov Iu.S., Demidov I.A., Lavnik D.V., Luk'ianchikov M.K.

More about the authors

Read: 648 times


To cite this article:

Safronenko AV, Makliakov IuS, Demidov IA, Lavnik DV, Luk'ianchikov MK. Condition and functional reserves of endothelium in patients with refractory arterial hypertension. Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(6):44‑47. (In Russ.)

Recommended articles:
The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medi­cine. 2024;(11):141-146
Features of arte­rial blood flow velo­city characteristics in endo­thelial dysfunction. Russian Journal of Preventive Medi­cine. 2024;(12):100-106
Correlation between endo­thelial dysfunction and sensorineural hearing loss. Russian Bulletin of Otorhinolaryngology. 2025;(3):13-18
Diagnostic stra­tegies for post-COVID syndrome. Russian Journal of Preventive Medi­cine. 2025;(6):126-130
Chro­nic kidney disease and microcirculation diso­rders. Russian Journal of Preventive Medi­cine. 2025;(8):123-130
«Metabolic health» and endo­thelial function in women with poly­cystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):27-34

References:

  1. Bezrodnaya L.V. Rezistentnaya (refrakternaya) arterial'naya gipertenziya. Arterial'naya gipertenziya 2011; 5: 5-9.
  2. Britov A.N., Bystrova M.M. Rezistentnaya arterial'naya gipertoniya: sovremennye podkhody k diagnostike i lecheniyu. Rats farmakoter v kardiol 2007; 2: 38-42.
  3. Vanin A.F. Oksid azota - regulyator kletochnogo metabolizma. Sorosovskii obrazovatel'nyi zhurn 2001; 11: 7-12.
  4. Vlasov S.P., Il'chenko M.Yu., Kazakov E.B. Disfunktsiya endoteliya i arterial'naya gipertenziya. M: Ofort 2010; 192.
  5. Lapshina L.A., Kravchun P.G., Titova A.Yu., Glebova O.V. Znachenie opredeleniya nitritov-nitratov kak markerov disfunktsii endoteliya pri serdechno-sosudistoi patologii. Ukr med chasopis 2009; 6: 49-56.
  6. Linchak R.M. Geneticheskie aspekty arterial'noi gipertenzii. Soobshchenie pervoe. Vestn tsentra im. N.I. Pirogova 2007; 1: 126-132.
  7. Manukhina E.B., Malyshev I.Yu. Rol' oksida azota v serdechno- sosudistoi patologii: vzglyad patofiziologa. Ros kardiol zhurn 2000; 5: 55-63.
  8. Mashina S.Yu., Smirin B.V., Pokidyshev D.A. Rol' preduprezhdeniya defitsita oksida azota v antigipertenzivnom effekte adaptatsii k gipoksii. Izvestiya AN (seriya biologiya) 2001; 5: 579-587.
  9. Pokrovskii V.I., Vinogradov N.A. Oksid azota, ego fiziologicheskie i patofiziologicheskie svoistva. Ter arkh 2005; 1: 82-87.
  10. Rekomendatsii po lecheniyu patsientov s pervichnoi (essentsial'noi) gipertenziei. Klinicheskie rekomendatsii №127. Metody, dokazatel'stva i rekomendatsii. Avgust 2011. Arterial'naya gipertenziya 2011; 5: 56-68.
  11. Cruz-González I., Corral E., Sánchez-Ledesma M. et al. Association between - T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study. BMC Cardiovasc Dis 2009; 9: 35.
  12. Erdine S. Resistant hypertension. European Society of Hypertension Scientific Newsletter. Update Hypertens Manag 2003; 4: 15-24.
  13. Swales J.D., Bing R.F., Heagerty A. et al. Treatment of refractory hypertension. Lancet 2002; 1: 894-896.
  14. Tamimi N.A. Resistant hypertension: a methodological approach to diagnosis and treatment. Saudi J Kidney Dis Transplant 2007; 18 (3): 337-345.
  15. Ting H.H., Timimi F.K., Haley E.A., Roddy M.A. et al. Vitamin S improves endothelium-dependent vasodilation in forearm vessels of humans with hypercholes-terolemia. Circulation 1997; 95: 2617-2622.
  16. Tobe S.W., Lewanczuk R. Resistant hypertension. Can J Cardiol 2009; 25 (5): 315-317.
  17. Vidt D.G. Resistant Hypertension. Hypertension: A Companion to Brenner and Rector's. In: The Kidney. Eds. S. Oparil, A. Weber. St. Louis: W.B. Saunders Company 2010; 757.
  18. Viera A.J., Hinderliter A.L. Evaluation and management of the patient with difficult-to-control or resistant hypertension. Am Family Physician; 79 (10): 863-869.
  19. Wenzel K., Haase N., Wallukat G. Potential relevance of a1-adrenergic receptor autoantibodies in refractory hypertension. PLoS ONE 2008; 3 (11): e3742.
  20. Zhu F., Sun Y., Liao Y. Agonistic AT1 receptor autoantibody increases in serum of patients with refractory hypertension and improves Ca2+ mobilization in cultured rat vascular smooth muscle cells. Cell Mol Immunol 2008; 5 (3): 209-217.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.